$GLUE
Monte Rosa Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Boston, MA
GLUE chart
What traders are saying about $GLUE
Latest postsMonte Rosa Therapeutics, Inc. news
- Monte Rosa Therapeutics, Inc. (GLUE) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Monte Rosa Therapeutics (GLUE) Stock Fair Value Edges Lower As Analysts Weigh NEK7 Promise And Risk
Yahoo Finance ·
- Monte Rosa Therapeutics (GLUE) Reports Promising Preclinical Dat
GuruFocus ·
- Monte Rosa Therapeutics, Inc. (GLUE) stock price, news, quote and history
Yahoo Finance Singapore ·
- Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2026 on the Potential of MRT-8102 in Gout
Yahoo Finance ·
- Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Has Consensus Target Price of $26.44
MarketBeat ·
- Monte Rosa Therapeutics (NASDAQ:GLUE) Upgraded to "Hold" at Wall Street Zen
MarketBeat ·
- Monte Rosa Therapeutics Stock Price Forecast. Should You Buy GLUE?
StockInvest.us ·
- Monte Rosa Therapeutics, Inc. (GLUE) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Wells Fargo & Company Issues Pessimistic Forecast for Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Price
MarketBeat ·
- Wells Fargo Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Cuts Target Price to $25
Moomoo ·
- Wells Fargo maintains Monte Rosa Therapeutics at Overweight, lowers price target to $25 from $27
TradingView ·
Monte Rosa Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$38.6M | -$72.7M | -$135.4M | -$108.5M |
| Total assets (year end) | $448.7M | $438.7M | $303.8M | $342.4M |
| Cash and equivalents (year end) | $129.9M | $224.3M | $128.1M | $54.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Monte Rosa Therapeutics, Inc.
- Ticker
- GLUE (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1826457
- Former names
- Monte Rosa Therapeutics, Inc.
Frequently asked questions
What exchange is Monte Rosa Therapeutics, Inc. listed on?
Monte Rosa Therapeutics, Inc. trades on the Nasdaq under the ticker symbol GLUE.
What industry is Monte Rosa Therapeutics, Inc. in?
Monte Rosa Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Monte Rosa Therapeutics, Inc. headquartered?
Monte Rosa Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Monte Rosa Therapeutics, Inc.'s fiscal year end?
Monte Rosa Therapeutics, Inc.'s fiscal year ends on December 31.